A vaporizing article, comprises a vaporizer drive circuit; one or more memories configured to store a percentage of at least one constituent in an inhalation media, one or more compensation values for at least one compensation category for the at least one constituent, and instructions; and a control circuit comprising a processor coupled with the one or more memories configured to run the instructions, the instructions configured to cause the processor to: receive a dose target for a constituent; determine whether to perform compensation for an inhalation media dose in order to ensure the dose target is met; when compensation is to be performed, determine the properly compensated inhalation media dose based on an associated compensation value for the constituent; and control the vaporizer drive circuit so as to dispense a compensated dose of the inhalation media.

A mist inhaler device (200) for generating a mist for inhalation by a user. The device includes a mist generator device (201) and a driver device (202). The driver device (202) is configured to drive the mist generator device (201) at an optimum frequency to maximise the efficiency of mist generation by the mist generator device (201).

An add-on device for a metered dose inhaler, an observance improvement system, and a method for improving observance of use in metered dose inhalers, the add-on device comprising an observance system housing component comprising an observance system with at least one pressure sensor; a mouthpiece component configured to fit, surround and removably engage with an exterior surface of a mouthpiece outlet provided on the metered dose inhaler; wherein the observance system housing is configured to fit and removably engage with the mouthpiece component; and the mouthpiece component is specifically adapted to conform to the exterior surface of the mouthpiece outlet of the metered dose inhaler without obstructing delivery of a dose of drug through the outlet.

An inhaler device is operable to deliver a dose of an inhalable active ingredient. The inhaler device comprises a housing comprising a mouthpiece, a removable flow regulator at least partly received within the housing, the flow regulator defining a cavity operable to receive a vessel comprising the active ingredient, and an electronic component operable to monitor inhaler data and to transmit the inhaler data to a remote device. An inhaler system comprises, together with an inhaler or inhaler cap, a computer programme application operable, when run on a client device, to cause the client device to receive inhaler data from the electronic component.

To be accompanied, when published, by FIG. 1 of the drawings.

Provided herein are dry powder formulations comprising epinephrine alone or in combination with at least one enabling agent suitable for nasal application. Also provided are unit dose forms and devices comprising such formulations and methods of using such formulations for the treatment of various conditions including anaphylaxis, anaphylactoid reaction, respiratory conditions, hemodynamic collapse, and for administration during cardiopulmonary arrest and other life-threatening conditions.

An intelligent vaporizing system includes a vaporizing device having a cartridge detachably coupled with a main body, the cartridge includes: a container configured to receive a liquid; a sensor for detecting a user’s action of inhalation; and a memory chip embedded inside the cartridge and communicated with the sensor, the memory chip configured to: record collected data from the sensor; receive associated data from an application; and transfer the collected data to the application; wherein the main body includes a heating element configured to heat the liquid to form a vaporized form; and a controller configured to receive the collected data and activate the heating element for heating the liquid.

The present disclosure relates generally to the field of nicotine delivery. The disclosure teaches a nicotine meta-salicylate. More specifically, the disclosure teaches a condensation nicotine aerosol where nicotine meta-salicylate is vaporized. This disclosure relates to aerosol nicotine delivery devices. The delivery devices can be activated by actuation mechanisms to vaporize thin films comprising a nicotine meta-salicylate. More particularly, this disclosure relates to thin films of nicotine salt with meta salicylic acid for the treatment of nicotine craving and for effecting smoking cessation.

The present invention includes and provides a method of delivering a medicament to an eye of a subject in need thereof a solution, the method comprising: (a) providing droplets containing the medicament with a specified average size and average initial ejecting velocity; and (b) delivering the medicament to the eye, where the droplets deliver a percentage of the ejected mass of the droplets to the eye.

A vaporizer device includes an inhalation nozzle, a container containing the vaporizable material; and an atomizer arranged for carrying out a single continual atomization process for producing an inhalable vapor. A dosage reminder system for the vaporizer device includes a control module, a reminder determination unit configured for detecting a parameter during the single continual atomization process of the atomizer and a reminder element arranged for providing a reminder effect under control of the control module when the parameter reaches to a predetermined threshold.

An aerosol provision device includes a microphone configured to detect a flow of air in the device and to output corresponding airflow detection signals to control circuitry. The control circuitry is configured to determine a duration of an inhalation by a user of the aerosol delivery device based on the airflow detection signals received from the microphone.